Results 151 to 160 of about 61,149 (183)

PTEN loss and ERBB2/ERBB3-mediated AKT reactivation drive resistance to MET inhibition in MET-amplified hepatocellular carcinoma. [PDF]

open access: yesCell Oncol (Dordr)
Qian R   +11 more
europepmc   +1 more source

Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity. [PDF]

open access: yesAntibodies (Basel)
Muzi A   +15 more
europepmc   +1 more source

Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer. [PDF]

open access: yesUnited European Gastroenterol J
Buchloh J   +15 more
europepmc   +1 more source

Table S1 from The Brain-Penetrant Pan-ErbB Inhibitor Poziotinib Effectively Targets HER2<sup>+</sup> Breast Cancer Brain Metastases

open access: gold
Danyyl Ippolitov   +15 more
openalex   +1 more source

Lipidomic and Transcriptomic Reveals Variations in Lipid Deposition During Goose Fatty Liver Formation. [PDF]

open access: yesBiology (Basel)
Zhang Q   +8 more
europepmc   +1 more source

Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia. [PDF]

open access: yesMol Ther Oncol
López A   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy